CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
• A subject must meet all the following criteria to participate in the registry:
‣ Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
⁃ Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
⁃ Is willing to provide consent for participation in the registry.
⁃ Is willing to provide Personal Information